India will produce about 300 million doses of the Russian Sputnik V coronavirus vaccine in 2021, Head of the Russian Direct Funding Fund (RDIF), Kirill Dmitriev, mentioned in an interview with Rossiya 24 TV channel.
“In India, we’ve got agreements with 4 giant producers. India will produce about 300 million doses or extra of the vaccine for us subsequent 12 months,” he mentioned, Russian information company Tass reported.
Dmitriev famous that out of 110 manufacturing websites that negotiated manufacturing of Sputnik V, RDIF selected 10 that meet its necessities. “The Russian Sputnik V will probably be actively produced on this planet and we see that that is constructed on a protected platform based mostly on the human adenovirus,” Dmitriev mentioned.
Earlier, Dmitriev had mentioned that manufacturing of Sputnik V started in different international locations, specifically in India, Korea, Brazil and China.
On August 11, Russia was the primary nation on this planet to register Sputnik V coronavirus vaccine. The drug handed scientific trials in June-July, post-registration research started in Moscow on September 7, whereas the volunteers acquired the primary vaccine on September 9.